G2083
HCPCSVisit esketamine, > 56m
Official HCPCS Level II long descriptor
Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation
HCPCS Level II code G2083 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Visit esketamine, > 56m
Added to HCPCS: 2020-01-01
Nearby codes in G2
- G2075Med tx meds nos
- G2076Intake act w/med exam
- G2077Periodic assessment
- G2078Take-home meth
- G2079Take-hom buprenorphine
- G2080Add 30 mins counsel
- G2081Pt 66+ snp or ltc pos > 90d
- G2082Visit esketamine 56m or less
- G2086Off base opioid tx 70min
- G2087Off base opioid tx, 60 m
- G2088Off base opioid tx, add30
- G2090Pt 66+ frailty and med dem
- G2091Pt 66+ frailty and adv ill
- G2092Ace arb arni
- G2093Med doc rsn no ace arn arni
- G2094Pt rsn no ace arn arni
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.